The Securities and Exchange Research Institute ushered in a busy period of research. According to the data, since November, brokerage firms have investigated a total of 328 listed companies, focusing on the electronics, mechanical equipment, pharmaceutical and biological industries. In the same period, brokerage firms adjusted the ratings of 18 listed companies, and the number is close to the full month of October. In terms of investment strategies, at the recent strategy meeting, many brokerage firms are still optimistic about the long-term narrative of technology, believing that there is an opportunity for valuation repair in the double innovation sector, which had a large pullback in the early stages.

The Securities and Exchange Research Institute ushered in a busy period of research. According to the data, since November, brokerage firms have investigated a total of 328 listed companies, focusing on the electronics, mechanical equipment, pharmaceutical and biological industries. In the same period, brokerage firms adjusted the ratings of 18 listed companies, and the number is close to the full month of October. In terms of investment strategies, at the recent strategy meeting, many brokerage firms are still optimistic about the long-term narrative of technology, believing that there is an opportunity for valuation repair in the double innovation sector, which had a large pullback in the early stages.